NeuPath Health Past Earnings Performance
Past criteria checks 0/6
NeuPath Health has been growing earnings at an average annual rate of 37.6%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 8.4% per year.
Key information
37.6%
Earnings growth rate
61.6%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 8.4% |
| Return on equity | -3.1% |
| Net Margin | -1.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel
Aug 18
These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively
Jun 16The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet
Apr 23Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?
Mar 01Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%
Dec 20Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues
Aug 19Revenue & Expenses Breakdown
How NeuPath Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 71 | -1 | 10 | 0 |
| 30 Jun 24 | 69 | 0 | 10 | 0 |
| 31 Mar 24 | 68 | 0 | 9 | 0 |
| 31 Dec 23 | 66 | 0 | 9 | 0 |
| 30 Sep 23 | 65 | -2 | 9 | 0 |
| 30 Jun 23 | 65 | -3 | 9 | 0 |
| 31 Mar 23 | 63 | -3 | 9 | 0 |
| 31 Dec 22 | 63 | -4 | 9 | 0 |
| 30 Sep 22 | 62 | -3 | 10 | 0 |
| 30 Jun 22 | 62 | -3 | 10 | 0 |
| 31 Mar 22 | 62 | -3 | 10 | 0 |
| 31 Dec 21 | 61 | -3 | 10 | 0 |
| 30 Sep 21 | 58 | -3 | 10 | 0 |
| 30 Jun 21 | 55 | -3 | 9 | 0 |
| 31 Mar 21 | 50 | -5 | 9 | 0 |
| 31 Dec 20 | 48 | -5 | 8 | 0 |
| 30 Sep 20 | 48 | -7 | 8 | 0 |
| 30 Jun 20 | 49 | -8 | 8 | 0 |
| 31 Mar 20 | 50 | -5 | 8 | 0 |
| 31 Dec 19 | 50 | -5 | 8 | 0 |
| 31 Dec 18 | 40 | -5 | 8 | 0 |
| 31 Dec 17 | 20 | -4 | 6 | 0 |
Quality Earnings: NPTH is currently unprofitable.
Growing Profit Margin: NPTH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NPTH is unprofitable, but has reduced losses over the past 5 years at a rate of 37.6% per year.
Accelerating Growth: Unable to compare NPTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NPTH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.8%).
Return on Equity
High ROE: NPTH has a negative Return on Equity (-3.11%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:09 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuPath Health Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Justin Keywood | Stifel Canada |